FTC Sues Drugmakers for Not Marketing Authorized Generics
Regulatory Focus The Federal Trade Commission (FTC) for the first time ever filed a complaint in federal district court this week alleging that an agreement not to market an authorized generic – often called a “no-AG commitment” – is a form of reverse payment and ... |
March 31, 2016 at 07:06PM | marketing - Google News
FTC Sues Drugmakers for Not Marketing Authorized Generics - Regulatory Focus
marketing - Google News